Human albumin: old, new, and emerging applications - PubMed (original) (raw)
Review
Human albumin: old, new, and emerging applications
Jacek Rozga et al. Ann Transplant. 2013.
Abstract
Human serum albumin has been widely used in an array of clinical settings for nearly 7 decades. Although there is no evidence to support the use of albumin rather than crystalloid in acute volume resuscitation, many clinicians continue to use albumin because it has other important physiologic effects besides the oncotic function. In keeping with the improved understanding of albumin physiology and pathophysiology of many acute and chronic diseases, use of albumin for medical applications has increased in recent years. This, along with increased costs of manufacturing and lower production volume of medical-grade albumin, has lead to an ongoing shortage and rapid increase in albumin prices. This review is based on the analysis of major publications, related to albumin chemistry, physiology, and medical uses including guidelines developed by professional and governmental organizations. Results reflect current knowledge about the role of albumin in health and disease and relevance of albumin therapy in specific clinical settings. Albumin therapy is currently recommended in spontaneous bacterial peritonitis with ascites, refractory ascites not responsive to diuretics, large-volume paracentesis, post-paracentesis syndrome, and the treatment of hepatorenal syndrome as an adjunct to vasoconstrictors. New indications for albumin therapy are linked to the antioxidant activity of albumin and its effects on capillary integrity. In recent years, large-pore hemofiltration and albumin exchange have emerged as promising liver support therapies for liver failure and other toxic syndromes. They are designed to remove a broad range of blood-borne toxins and to restore normal functions of the circulating albumin by replacing defective forms of albumin and albumin molecules saturated with toxins with normal albumin. In view of the ongoing worldwide shortage and high cost of human albumin (native and recombinant), new usage criteria, protocols, and guidelines for appropriate utilization of albumin are needed.
Similar articles
- Clinical indications for the albumin use: still a controversial issue.
Caraceni P, Domenicali M, Tovoli A, Napoli L, Ricci CS, Tufoni M, Bernardi M. Caraceni P, et al. Eur J Intern Med. 2013 Dec;24(8):721-8. doi: 10.1016/j.ejim.2013.05.015. Epub 2013 Jun 20. Eur J Intern Med. 2013. PMID: 23790570 Review. - Hypoalbuminemia.
Gatta A, Verardo A, Bolognesi M. Gatta A, et al. Intern Emerg Med. 2012 Oct;7 Suppl 3:S193-9. doi: 10.1007/s11739-012-0802-0. Intern Emerg Med. 2012. PMID: 23073857 Review. - [Current role of albumin in critical care].
Aguirre Puig P, Orallo Morán MA, Pereira Matalobos D, Prieto Requeijo P. Aguirre Puig P, et al. Rev Esp Anestesiol Reanim. 2014 Nov;61(9):497-504. doi: 10.1016/j.redar.2014.04.016. Epub 2014 Jun 18. Rev Esp Anestesiol Reanim. 2014. PMID: 24952825 Review. Spanish. - Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.
Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R. Garcia-Martinez R, et al. Hepatology. 2013 Nov;58(5):1836-46. doi: 10.1002/hep.26338. Epub 2013 May 14. Hepatology. 2013. PMID: 23423799 Review. - Drug insight: the role of albumin in the management of chronic liver disease.
Wong F. Wong F. Nat Clin Pract Gastroenterol Hepatol. 2007 Jan;4(1):43-51. doi: 10.1038/ncpgasthep0680. Nat Clin Pract Gastroenterol Hepatol. 2007. PMID: 17203088 Review.
Cited by
- Assessment of Albumin Usage Patterns and Appropriateness in a Comprehensive Cancer Centre: A retrospective study in Jordan.
Al-Kharabsheh AA, Nazer LH, Awad W, Ghanem A, Al-Hadaddin R, Amer BB, Thawaibeh H, Mustafa N, Al-Najjar R, Al-Rabayah A, Jaddoua S. Al-Kharabsheh AA, et al. Sultan Qaboos Univ Med J. 2024 Aug;24(3):354-359. doi: 10.18295/squmj.6.2024.029. Epub 2024 Aug 29. Sultan Qaboos Univ Med J. 2024. PMID: 39234319 Free PMC article. - The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.
Abdelhamid S, Achermann R, Hollinger A, Hauser M, Trutmann M, Gallacchi L, Siegemund M. Abdelhamid S, et al. Crit Care Med. 2024 May 1;52(5):e234-e244. doi: 10.1097/CCM.0000000000006218. Epub 2024 Feb 7. Crit Care Med. 2024. PMID: 38502807 Free PMC article. - Clinical Characteristics and Survival of Hepatocellular Carcinoma: Insights from Single-Centre Experience in Saudi Arabia.
Badheeb AM, Al Sedran MK, Ahmed F, Al Sidran IK, Al Qurayshah MH, Abu Bakar A, Obied HY, Seada IA, Aman A, Badheeb M. Badheeb AM, et al. Cureus. 2024 Jan 20;16(1):e52608. doi: 10.7759/cureus.52608. eCollection 2024 Jan. Cureus. 2024. PMID: 38374854 Free PMC article. - Serum Albumin Level Can Predict Immunotherapy Response of Neuromyelitis Optica Spectrum Disorders in the Acute Phase.
Xiang W, Wu Y, Li H, Zhu D, Yao X, Ding J, Wang Z, Guan Y. Xiang W, et al. J Inflamm Res. 2024 Feb 12;17:909-917. doi: 10.2147/JIR.S442532. eCollection 2024. J Inflamm Res. 2024. PMID: 38370469 Free PMC article. - Role of Preoperative Albumin Quotient in Surgical Planning for Posttraumatic Syringomyelia: A Comparative Cohort Study.
Xia P, Lv H, Yuan C, Duan W, Wang J, Guan J, Du Y, Zhang C, Liu Z, Wang K, Wang Z, Wang X, Wu H, Chen Z, Jian F. Xia P, et al. Neurospine. 2024 Mar;21(1):212-222. doi: 10.14245/ns.2347152.576. Epub 2024 Feb 1. Neurospine. 2024. PMID: 38317552 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources